Inquirer on MSN3d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...
Irish Examiner on MSN1d
Nasal irrigation: Breathe easy by flushing out your nasal cavityNasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
Emergent BioSolutions (EBS) announced that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro football legend ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III study to confirm the efficacy and safety of Stapokibart injection in treatment of adult patients with ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.
Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback